Citations

Showing 10 of 108104 citations.

Prevalence of co‐occurring serious illness diagnoses and association with health care utilization at the end of life
Nothelle, Stephanie , Jacobson, Debra J., Green, Ariel R. , Boyd, Cynthia M. , Rocca, Walter A. , Fan, Chun , Jacobson, Debra, Green, Ariel R , Nothelle, Stephanie , Chamberlain, Alanna M. , Sauver, Jennifer L. St.

Mayo Clinic

Journal of the American Geriatrics Society | May 20, 2022 | Volume: 70 | Issue: 9 | Pages: 2621-2629

10.1111/jgs.17881 | PMID 35593458 Get It

Abstract Introduction End‐of‐life care differs by serious illness diagnosis. Cancer and dementia are serious illnesses that have been associated with less intensive end‐of‐life health care use. It is not known how health care utilization varies in the presence of >1 serious illness. Methods We used the Rochester Epidemiology Project to identify persons living in a midwestern area who died on July 1, 2017–June 30, 2018 at age ≥65 years, and were seriously ill. We examined the number of emergency department (ED), hospital, and intensive care unit (ICU) stays in the last 6 months and the last 30 days of life. We used Poisson regression to determine the incidence rate ratio for ED, hospital, and ICU stay in the last 6 months and 30 days of life by number of serious illness diagnoses. For cancer and dementia, we examined the effect of an additional serious illness. Results We included a population of 1372 adults who were, on average, 84 years, 52% female, and 96% white. Approximately 41% had multiple serious illnesses. Compared to older adults with 1 serious illness diagnosis, rates of hospitalization, and ICU stay for adults with 2 or ≥3 serious illness diagnoses were at least 1.5 times higher in the last 6 months and the last 30 days of life. Rates of ED visits were significantly higher for older adults with 2 or ≥3 serious illness diagnoses in the last 6 months of life, but only higher for those with ≥3 versus 1 serious illness diagnosis in the last 30 days of life. For both cancer and dementia, rates of ED visits, hospitalization and ICU stay were lower for the condition alone than when an additional serious illness diagnosis was present. Conclusion Having multiple serious illnesses increases the risk of health care utilization at the end of life.
Catheter ablation for atrial fibrillation in the elderly >75 years old: Systematic review and meta‐analysis
Prasitlumkum, Narut , Tokavanich, Nithi , Cheungpasitporn, Wisit, Kewcharoen, Jakrin , Chokesuwattanaskul, Ronpichai , Akoum, Nazem , Bunch, T. Jared , Navaravong, Leenhapong , Cheungpasitporn, Wisit , Kewcharoen, Jakrin , Chokesuwattanaskul, Ronpichai , Akoum, Nazem , Navaravong, Leenhapong , Cheungpasitporn, Wisit , Prasitlumkum, Narut , Trongtorsak, Angkawipa

Mayo Clinic

Journal of Cardiovascular Electrophysiology | May 20, 2022 | Volume: 33 | Issue: 7 | Pages: 1435-1449

10.1111/jce.15549 | PMID 35589557 Get It

AbstractIntroductionAtrial fibrillation (AF) ablation is increasingly performed worldwide. As comfort with AF ablation increases, the procedure is increasingly used in patients that are older and in those with more comorbidities. However, it is not well established whether AF ablation in the elderly, especially those >75 years old, has comparable safety and efficacy to younger populations.ObjectiveTo compare the efficacy and safety profiles in patients older than 75 years undergoing AF ablation with younger patients.MethodsDatabases from EMBASE, Medline, PubMed, and Cochrane, were searched from inception through September 2021. Studies that compared the success rates in AF catheter ablation and all complications rates between patients who were older vs under 75 years were included. Effect estimates from the individual studies were extracted and combined using random effect, generic inverse variance method of DerSimonian and Laird.ResultsTwenty‐seven observational studies were included in the analysis consisting of 363,542 patients who underwent AF ablation. Comparing patients older than 75 years old to younger patients, there was no difference in the success of ablation rates between elderly and younger patients (pooled OR 0.85: 95% CI:0.69–1.05, p = .131). On the other hand, AF ablation in the elderly was associated with higher complication rates (pooled OR 1.42: 95% CI:1.21–1.68, p < .001).ConclusionAs AF ablation is expanded to elderly populations, our study found that AF ablation success rates were similar in both elderly and younger patients. However, older patients experience higher rates of complications that should be considered when offering the procedure and as a means to improve outcomes with future innovations.
Updates on Measles Incidence and Eradication: Emphasis on the Immunological Aspects of Measles Infection
Rabaan, Ali A. , Mutair, Abbas Al , Alhumaid, Saad , Garout, Mohammed , Alsubki, Roua A. , Alshahrani, Fatimah , Alfouzan, Wadha , Alestad, Jeehan H., Alsaleh, Abdullah E., Al-Mozaini, Maha , Koritala, Thoyaja , Alotaibi, Sultan , Temsah, Mohamad‐Hani , Akbar, Ali , Ahmad, Rafiq , Khalid, Zainab , Muhammad, Javed , Ahmed, Naveed , Alfouzan, Wadha A , Alhumaid, Saad , Rabaan, Ali A

Mayo Clinic

Medicina | May 20, 2022 | Volume: 58 | Issue: 5 | Pages: 680

10.3390/medicina58050680 | PMID 35630096 Get It

Measles is an RNA virus infectious disease mainly seen in children. Despite the availability of an effective vaccine against measles, it remains a health issue in children. Although it is a self-limiting disease, it becomes severe in undernourished and immune-compromised individuals. Measles infection is associated with secondary infections by opportunistic bacteria due to the immunosuppressive effects of the measles virus. Recent reports highlight that measles infection erases the already existing immune memory of various pathogens. This review covers the incidence, pathogenesis, measles variants, clinical presentations, secondary infections, elimination of measles virus on a global scale, and especially the immune responses related to measles infection.
Beyond Self-Promotion: The New Landscape of Social Media Use in Clinical Practice and Career Development
Koo, Kevin , Malik, Rena D.

Mayo Clinic

Urology Practice | May 19, 2022 | Volume: 9 | Issue: 4 | Pages: 267-269

10.1097/upj.0000000000000318 | PMID 37145798 Get It

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer
Bittner, Nathan, Cox, Brett, King, Martin T. , Lawton, C.A., Orio, Peter F. , Ouhib, Zoubir , Rossi, Peter J. , Schechter, Naomi R., Davis, Brian J. , Merrick, Gregory Stephen , Showalter, Timothy N. , Small, William

Mayo Clinic

American Journal of Clinical Oncology | May 19, 2022 | Volume: 45 | Issue: 6 | Pages: 249-257

10.1097/coc.0000000000000915 | PMID 35588224 Get It

Aim/Objectives/Background: The American College of Radiology (ACR), American Brachytherapy Society (ABS), and American Society for Radiation Oncology (ASTRO) have jointly developed the following practice parameter for transperineal permanent brachytherapy of prostate cancer. Transperineal permanent brachytherapy of prostate cancer is the interstitial implantation of low-dose rate radioactive seeds into the prostate gland for the purpose of treating localized prostate cancer. Methods: This practice parameter was developed according to the process described under the heading The Process for Developing ACR Practice Parameters and Technical Standards on the ACR website (https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters—Radiation Oncology of the Commission on Radiation Oncology, in collaboration with ABS and ASTRO. Results: This practice parameter provides a framework for the appropriate use of low-dose rate brachytherapy in the treatment of prostate cancer either as monotherapy or as part of a treatment regimen combined with external-beam radiation therapy. The practice parameter defines the qualifications and responsibilities of all involved radiation oncology personnel, including the radiation oncologist, medical physicist, dosimetrist, radiation therapist, and nursing staff. Patient selection criteria and the utilization of supplemental therapies such as external-beam radiation therapy and androgen deprivation therapy are discussed. The logistics of the implant procedure, postimplant dosimetry assessment, and best practices with regard to safety and quality control are presented. Conclusions: Adherence to established standards can help to ensure that permanent prostate brachytherapy is delivered in a safe and efficacious manner.
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement
Oyer, Randall A. , Hurley, Patricia A. , Boehmer, Leigh , Bruinooge, Suanna S. , Levit, Kathryn , Barrett, Nadine J. , Benson, Al B. , Bernick, Lea Ann, Byatt, Leslie, Charlot, Marjory , Crews, Jennie R. , DeLeon, Kyle, Green, Sybil, Guerra, Carmen E. , Hamroun, Leila, Hardy, Claudia M. , Hempstead, Bridgette, Jeames, Sanford , Mann, Mel , Matin, Khalid , McCaskill‐Stevens, Worta , Merrill, Janette K. , Nowakowski, Grzegorz S. , Patel, Manali I. , Pressman, Alice , Segura, Juanita, Segarra-Vasquez, Barbara, Williams, Jen Hanley, Williams, J.E. Caerwyn , Winkfield, Karen M. , Yang, Eddy S. , Zwicker, Victoria, Pierce, Lori J. , Hurley, Patricia , Bruinooge, Suanna Steeby , Barrett, Nadine , Benson, Al , Fashoyin-Aje, Lola , Garrett-Mayer, Elizabeth , Gralow, Julie R , Guerra, Carmen E , Jeames, Sanford , Mann, Mel , Merrill, Janette , Nowakowski, Grzegorz S , Patel, Manali I , Pressman, Alice , Ramirez, Amelie G , Hanley Williams, Jen , Williams, James E , Winkfield, Karen M , Yang, Eddy S , Pierce, Lori J , Charlot, Marjory , Oyer, Randall A , Garrett‐Mayer, Elizabeth , Gralow, Julie R. , Segarra-Vasquez, Barbara

Mayo Clinic

Journal of Clinical Oncology | May 19, 2022 | Volume: 40 | Issue: 19 | Pages: 2163-2171

10.1200/jco.22.00754 | PMID 35588469 Get It

A concerted commitment across research stakeholders is necessary to increase equity, diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and participation. Racial and ethnic diversity among trial participants is key to understanding intrinsic and extrinsic factors that may affect patient response to cancer treatments. This ASCO and Association of Community Cancer Centers (ACCC) Research Statement presents specific recommendations and strategies for the research community to improve EDI in cancer clinical trials. There are six overarching recommendations: (1) clinical trials are an integral component of high-quality cancer care, and every person with cancer should have the opportunity to participate; (2) trial sponsors and investigators should design and implement trials with a focus on reducing barriers and enhancing EDI, and work with sites to conduct trials in ways that increase participation of under-represented populations; (3) trial sponsors, researchers, and sites should form long-standing partnerships with patients, patient advocacy groups, and community leaders and groups; (4) anyone designing or conducting trials should complete recurring education, training, and evaluation to demonstrate and maintain cross-cultural competencies, mitigation of bias, effective communication, and a commitment to achieving EDI; (5) research stakeholders should invest in programs and policies that increase EDI in trials and in the research workforce; and (6) research stakeholders should collect and publish aggregate data on racial and ethnic diversity of trial participants when reporting results of trials, programs, and interventions to increase EDI. The recommendations are intended to serve as a guide for the research community to improve participation rates among people from racial and ethnic minority populations historically under-represented in cancer clinical trials. ASCO and ACCC will work at all levels to advance the recommendations in this publication.
Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn’s Disease Biopsies
Lefèvre, Pavine, Guizzetti, Leonardo , Zou, Guangyong , Viegen, Tanja van, McFarlane, Stefanie C., Shackelton, Lisa M. , Feagan, Brian G. , Jairath, Vipul , Pai, Rish K. , Jairath, Vipul , Jairath, Vipul , Guizzetti, L , Jairath, V , Jairath, V , Jairath, Vipul , Zou, Guangyong , McKee, Trevor D. , Casteele, Niels Vande

Mayo Clinic

Applied Immunohistochemistry & Molecular Morphology | May 19, 2022 | Volume: 30 | Issue: 7 | Pages: 486-492

10.1097/pai.0000000000001035 | PMID 35587994 Get It

The T-lymphocyte–mediated inflammation in Crohn's disease can be assessed by quantifying CD3-positive T-lymphocyte counts in colonic sections. We developed and validated a process to reliably quantify immunohistochemical marker-positive cells in a high-throughput setting using whole slide images (WSIs) of CD3-immunostained colonic and ileal tissue sections. In regions of interest (ROIs) and/or whole tissue sections of 40 WSIs from 36 patients with Crohn's disease, CD3-positive cells were quantified by an expert gastrointestinal pathologist (gold standard) and by image analysis algorithms developed with software from 3 independent vendors. Semiautomated quantification of CD3-positive cell counts estimated in 1 ROI per section were accurate when compared with manual analysis (Pearson correlation coefficient, 0.877 to 0.925). Biological variability was acceptable in digitally determined CD3-positive cell measures between 2 to 5 ROIs annotated on the same tissue section (coefficient of variation <25%). Results from computer-aided analysis of CD3-positive T lymphocytes in a whole tissue section and the average of results from 2 to 5 ROIs per tissue section lacked reliability (overestimation or underestimation and systematic bias), suggesting that absolute quantification of CD3-positive T lymphocytes in a whole tissue section may be more accurate. Semiautomated image analysis in WSIs demonstrated reproducible CD3-positive cell measures across 3 independent algorithms. A computer-aided digital image analysis method was developed and validated to quantify CD3-positive T lymphocytes in colonic and ileal biopsy sections from patients with Crohn's disease. Results support consideration of this digital analysis method for use in future Crohn's disease clinical studies.
Kotter's 8-step change model to improve hand hygiene compliance in Intensive Care Unit: a 41-month prospective longitudinal quality improvement study
Hu, Fen, Cao, Rui, Feng, Bilong , Li, Jin , Ding, Xinbo, Xu, Ying , Xu, Dandan, Pei, Juanjuan, Liang, Ke , Peng, Zhiyong , Yuan, Yufeng , Wang, Ying , Hu, Chang , Ma, Jing , Li, Huilin, Wang, Pei , Zhu, Xiaoping , Chen, Jie, Liang, Ke , Kashani, Kianoush , Hu, Bo

Mayo Clinic

No container title available | May 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1599065/v1 Get It

Abstract BackgroundMany studies have evaluated bundled interventions to improve hand hygiene compliance (HHC). However, the compliance rates remain low. We aimed to use Kotter's change model (KCM) to improve HHC and conduct a complete process evaluation for HHC among medical staff in the intensive care unit (ICU). MethodsKCM was administrated in the ICU of Zhongnan Hospital of Wuhan University from March 2018 to August 2021, and 41-month longitudinal monitoring of HHC was carried out. The primary outcome was the absolute change in monthly HHC. The secondary outcomes included the characteristics of HHC in different phases, the different change trends of HHC for different HH opportunities and occupations, the quarterly incidence of the central line-associated bloodstream infection (CLABSI), and the catheter-associated urinary tract infection (CAUTI).Results. 20,222 HH actions and 24,195 HH opportunities were included in this study. The overall HHC was 83.58% (95%CI, 83.11%-84.04%). After implementing the KCM project, the HHC increased from 35.71% (95%CI, 22.99%-50.83%) to 87.75% (95%CI, 85.53%-89.67%), with an increased rate of 145.73%. The fastest-growing rate of HHC was after contact patients, which increased from 35.29% to 89.8%. Quarterly trends of the CLABSI rate (0‰-3.53‰) and CAUTI rate (0.96‰-4.26‰) remained stable at a low level under the background of the number of cases and the treatment complexities of the patients increasing year by year.ConclusionsUsing KCM can systematically change the cognition of HH in healthcare providers and create an atmosphere to promote HH to improve and maintain the stability of the HHC of healthcare providers in ICU.
Pressure Injury Prediction Model Using Advanced Analytics for At-Risk Hospitalized Patients
Lipatov, Kirill , Ramar, Kannan , Rasmusson, Jenna, Pickering, Brian W. , Do, Quan, Herasevich, Vitaly

Mayo Clinic

Journal of Patient Safety | May 19, 2022 | Volume: 18 | Issue: 7 | Pages: e1083-e1089

10.1097/pts.0000000000001013 | PMID 35588068 Get It

Objective Analyzing pressure injury (PI) risk factors is complex because of multiplicity of associated factors and the multidimensional nature of this injury. The main objective of this study was to identify patients at risk of developing PI. Method Prediction performances of multiple popular supervised learning were tested. Together with the typical steps of a machine learning project, steps to prevent bias were carefully conducted, in which analysis of correlation covariance, outlier removal, confounding analysis, and cross-validation were used. Result The most accurate model reached an area under receiver operating characteristic curve of 99.7%. Ten-fold cross-validation was used to ensure that the results were generalizable. Random forest and decision tree had the highest prediction accuracy rates of 98%. Similar accuracy rate was obtained on the validation cohort. Conclusions We developed a prediction model using advanced analytics to predict PI in at-risk hospitalized patients. This will help address appropriate interventions before the patients develop a PI.
Intraoperative defibrillation testing during replacements of implantable cardioverter-defibrillators: The Simpler trial
Nof, Eyal , Regev, Ehud , Rav, Moshe , Kutyifa, Valentina, Merkely, B, Biffi, M, Cha, YM, Ovdat, T, Klempfner, R., Glikson, Michael , Milman, Anat , Beinart, Roy , Kutyifa, Valentina , Biffi, Mauro , Ovdat, T, Glikson, Michael

Mayo Clinic

EP Europace | May 19, 2022 | Volume: 24 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euac053.461 Get It

Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding source(s): Maurice Kahn Foundation via the Mayo- Sheba Collaboration Fund. Background The need for intraoperative defibrillation testing (DFT) during implant and/or replacement of implantable cardioverter-defibrillators (ICDs) has been a matter of debate for many years. This debate was put to rest by the Simple and the Nordic ICD trials, and the practice of testing during new implantations has practically been nearly abandoned. Nevertheless, induction of VF for testing purposes (VFT) may still have an important role in selective populations at risk for defibrillation failure, who were not included in the SIMPLE and Nordic trials. One such population includes those who undergo device replacements. Old registries demonstrated an increased incidence of significant findings in VFT during replacements. In the present study, we sought to test this observation. Objectives Evaluate frequency of significant findings and the safety of VFT in subjects undergoing device replacement. Methods A prospective observational multi-center study of VFT included consecutive patients undergoing ICD generator replacement in 5 centers in Israel, Europe, and the US. All centers followed the same VFT protocol. The primary outcome was defined as failure to terminate induced VF with a single shock at 10 Joules below the maximal capacity of the device. Secondary outcomes included complications of VFT. Patients were followed-up at 1 month and 6 months post-procedure. Data collection included documentation of any peri-operative complications and clinical endpoints (occurrence of appropriate shock, inappropriate shocks, lead failure, need for re-intervention, and infection). Results A total of 92 patients were eligible, and consented for the study, of which 84 underwent DFT during battery replacement. The median age was 68 years and 79.8% were male subjects. Induction of VF was successful in all 84 patients as well as VFT with a successful conversion on first attempt. During follow up one patient had two appropriate ICD shock events. In four patients, the ICD programming was changed. None suffered an inappropriate shock. There was no evidence of lead malfunction. A total of two deaths occurred, none of which were related to the device. Conclusion The present study found VFT was not associated with complications in patients undergoing ICD/CRTD generator replacement but produced no clinically important information.